Search
for
Sort by
Research 841–870 of 1000+
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Alopecia and its medical management
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Cosmetic Approach for Men
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Genetic Defects of Female Sexual Differentiation
- Conventional and novel stem cell based therapies for androgenic alopecia
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang
- Metabolic Syndrome and Skin Diseases
- Cell Therapy for Androgenetic Alopecia: Elixir or Trick?
- A systematic summary of survival and death signalling during the life of hair follicle stem cells
- Systemic causes of hair loss
- The impact of oxidative stress on hair
- Cause of Androgenic Alopecia
- New Target for Minoxidil in the Treatment of Androgenetic Alopecia
- Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris
- Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
- Sex steroid synthesis in human skin in situ: The roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin
- Current Literature Review
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Drugs and Androgenetic Alopecia: What to look out for
- Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study
- Anti-androgenic therapy with finasteride in patients with chronic heart failure – a retrospective propensity score based analysis
- Nucleus‐specific modulation of phasic and tonic inhibition by endogenous neurosteroidogenesis in the murine thalamus